Gabriela Lobinska

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Candida Albicans

Drug Administration

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriela Lobinska, Vyacheslav Tretyachenko, Orna Dahan, Martin A Nowak, Yitzhak Pilpel
The evolutionary safety of mutagenic drugs should be assessed before drug approval. PLoS biology 22 (3) (2024)
Gabriela Lobinska, Vyacheslav Tretyachenko, Orna Dahan, Martin A Nowak, Yitzhak Pilpel
The evolutionary safety of mutagenic drugs should be assessed before drug approval. PLoS biology 22 (3) (2024)
Gabriela Lobinska, Vyacheslav Tretyachenko, Orna Dahan, Martin A Nowak, Yitzhak Pilpel
The evolutionary safety of mutagenic drugs should be assessed before drug approval. PLoS biology 22 (3) (2024)
Gabriela Lobinska, Vyacheslav Tretyachenko, Orna Dahan, Martin A Nowak, Yitzhak Pilpel
The evolutionary safety of mutagenic drugs should be assessed before drug approval. PLoS biology 22 (3) (2024)
Gabriela Lobinska, Yitzhak Pilpel, Martin A Nowak
Evolutionary safety of lethal mutagenesis driven by antiviral treatment. PLoS biology 21 (8) (2023)